Peritoneal carcinomatosis arising from rectal or colonic adenocarcinoma treated with cytoreductive surgery (CRS) hyperthermic intraperitoneal chemotherapy (HIPEC): two different diseases.
Marco TonelloG Ortega-PerezO Alonso-CasadoP Torres-MesaG GuiñezS Gonzalez-MorenoPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2018)
Rectal origin PC has a more aggressive behavior compared to colonic origin, reflecting in a worst prognosis of patients affected by rectal origin PC. According to our data and literature, indications of multi-modal treatment including CRS and HIPEC should be more restrictive for rectal cancer PC. Authors should differentiate colonic and rectal origin of PC when reporting cases in the literature.
Keyphrases
- rectal cancer
- locally advanced
- systematic review
- end stage renal disease
- newly diagnosed
- ulcerative colitis
- ejection fraction
- minimally invasive
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- emergency department
- machine learning
- acute coronary syndrome
- big data
- atrial fibrillation
- electronic health record
- radiation therapy
- replacement therapy
- artificial intelligence
- combination therapy
- drug induced
- chemotherapy induced